Thomas B. McClanahan

634 total citations
24 papers, 465 citations indexed

About

Thomas B. McClanahan is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Thomas B. McClanahan has authored 24 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pathology and Forensic Medicine and 7 papers in Surgery. Recurrent topics in Thomas B. McClanahan's work include Cardiac Ischemia and Reperfusion (9 papers), Cardiac Imaging and Diagnostics (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Thomas B. McClanahan is often cited by papers focused on Cardiac Ischemia and Reperfusion (9 papers), Cardiac Imaging and Diagnostics (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Thomas B. McClanahan collaborates with scholars based in United States, Spain and China. Thomas B. McClanahan's co-authors include Kim P. Gallagher, K P Gallagher, Thomas Mertz, Lakshmi Narasimhan, Jeremy J. Edmunds, Markus Schwaiger, Wayne L. Cody, Danette A. Dudley, Robert J. Schott and Liguo Chi and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas B. McClanahan

24 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas B. McClanahan United States	13	144	137	104	85	68	24	465
A. van der Laarse Netherlands	15	381 2.6×	20 0.1×	112 1.1×	188 2.2×	192 2.8×	38	703
David J. Blomberg United States	11	97 0.7×	59 0.4×	24 0.2×	56 0.7×	108 1.6×	24	375
Guangxian Chen China	12	164 1.1×	53 0.4×	42 0.4×	8 0.1×	181 2.7×	46	523
Hua He China	14	153 1.1×	157 1.1×	26 0.3×	31 0.4×	100 1.5×	42	552
David Haybron United States	8	86 0.6×	15 0.1×	175 1.7×	8 0.1×	50 0.7×	9	457
Simone Bonoron‐Adèle France	14	433 3.0×	9 0.1×	181 1.7×	201 2.4×	236 3.5×	22	763
Mary E. Duffy United States	7	152 1.1×	24 0.2×	44 0.4×	110 1.3×	198 2.9×	8	486
Miroslav Ferko Slovakia	14	115 0.8×	10 0.1×	155 1.5×	42 0.5×	268 3.9×	38	521
Cynthia A. Fink United States	13	387 2.7×	60 0.4×	20 0.2×	172 2.0×	157 2.3×	28	637
Dhvanit I. Shah India	13	52 0.4×	82 0.6×	17 0.2×	101 1.2×	122 1.8×	22	462

Countries citing papers authored by Thomas B. McClanahan

Since Specialization

Citations

This map shows the geographic impact of Thomas B. McClanahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas B. McClanahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas B. McClanahan more than expected).

Fields of papers citing papers by Thomas B. McClanahan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas B. McClanahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas B. McClanahan. The network helps show where Thomas B. McClanahan may publish in the future.

Co-authorship network of co-authors of Thomas B. McClanahan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas B. McClanahan. A scholar is included among the top collaborators of Thomas B. McClanahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas B. McClanahan. Thomas B. McClanahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casimiro‐Garcia, Agustin, Christopher F. Bigge, Wayne L. Cody, et al.. (2009). Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorganic & Medicinal Chemistry. 17(6). 2501–2511. 17 indexed citations

McClanahan, Thomas B., Kathleen M. Welch, Sangita M. Baxi, et al.. (2006). Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro. Journal of Thrombosis and Haemostasis. 4(4). 834–841. 14 indexed citations

Willardsen, J. Adam, Danette A. Dudley, Wayne L. Cody, et al.. (2004). Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 47(16). 4089–4099. 107 indexed citations

McClanahan, Thomas B., et al.. (2001). The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis. European Journal of Pharmacology. 432(2-3). 187–194. 12 indexed citations

McClanahan, Thomas B., et al.. (2000). The Antithrombotic Effects of CI-1028, an Orally Bioavailable Direct Thrombin Inhibitor, in a Canine Model of Venous and Arterial Thrombosis. Journal of Thrombosis and Thrombolysis. 10(3). 277–284. 8 indexed citations

Dudley, Danette A., Amy Bunker, Liguo Chi, et al.. (2000). Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors. Journal of Medicinal Chemistry. 43(22). 4063–4070. 37 indexed citations

McClanahan, Thomas B., et al.. (1999). Antithrombotic Effects of BCH 2763, a New Direct Thrombin Inhibitor, in a Canine Model of Venous Thrombosis. Journal of Thrombosis and Thrombolysis. 7(3). 301–306. 6 indexed citations

McClanahan, Thomas B., et al.. (1997). Effects of endothelin ETA receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits. European Journal of Pharmacology. 321(3). 295–300. 14 indexed citations

McClanahan, Thomas B., et al.. (1997). Effects of ischemia, preconditioning, and adenosine deaminase inhibition on interstitial adenosine levels and infarct size. Basic Research in Cardiology. 92(4). 240–251. 23 indexed citations

10.

McClanahan, Thomas B., et al.. (1996). Effects of Endothelin-Receptor Antagonism with PD156707 on Myocardial Stunning in Swine. Journal of Cardiovascular Pharmacology. 28(5). 679–686. 6 indexed citations

11.

McClanahan, Thomas B., Paul Juneau, Elwood E. Reynolds, et al.. (1996). Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 42–49. 12 indexed citations

12.

McClanahan, Thomas B., et al.. (1995). Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs. Basic Research in Cardiology. 90(2). 176–183. 15 indexed citations

13.

Gallagher, Kim P., Thomas B. McClanahan, Bradley J. Martin, et al.. (1995). Does Adenosine Deaminase Inhibition Protect Ischemic Myocardium?. Advances in experimental medicine and biology. 370. 291–294. 3 indexed citations

14.

Conn, Carole A., et al.. (1994). Tumor Necrosis Factor and Interleukin-6 Are Not Elevated in Venous Blood from Ischemic Canine Myocardium. Experimental Biology and Medicine. 206(4). 384–391. 3 indexed citations

15.

Stirling, Mack C., Michael Choy, Thomas B. McClanahan, Robert J. Schott, & Kim P. Gallagher. (1991). Effects of ischemia on epicardial segment shortening. Journal of Surgical Research. 50(1). 30–39. 5 indexed citations

16.

Forder, John R., Thomas B. McClanahan, Kim P. Gallagher, et al.. (1990). Hemodynamic Effects of Intraatrial Administration of Deferoxamine or Deferoxamine-Pentafraction Conjugate to Conscious Dogs. Journal of Cardiovascular Pharmacology. 16(5). 742–749. 9 indexed citations

17.

McClanahan, Thomas B., et al.. (1990). The time limit of effective ischemic preconditioning in dogs. 3. 271. 17 indexed citations

18.

Schwaiger, Markus, Karen C. Rosenspire, Thomas B. McClanahan, et al.. (1990). Effect of regional myocardial ischemia on sympathetic nervous system as assessed by fluorine-18-metaraminol.. PubMed. 31(8). 1352–7. 40 indexed citations

19.

Stirling, Mack C., Thomas B. McClanahan, Robert J. Schott, et al.. (1989). Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts. Journal of Thoracic and Cardiovascular Surgery. 98(6). 1066–1076. 48 indexed citations

20.

Lynch, Joseph J., et al.. (1988). Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury. American Heart Journal. 115(6). 1171–1182. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact